A design strategy that minimizes the susceptibility of HIV-1 protease inhibitors to mutations causing drug resistance

Researcher: 
Velázquez Campoy, Adrián
Congress: 
16th Meeting of Groups Studying the Structures of AIDS-related Systems and their Application to Targeted Drug Design (NIH)
Participation type: 
Comunicación oral
Other authors: 
A. Velazquez-Campoy, I. Luque, S. Muzammil, H. Ohtaka, S. Vega, P. Ross, E. Freire
Year: 
2002
Location: 
Bethesda
Publication: 
A. Velazquez-Campoy, I. Luque, S. Muzammil, H. Ohtaka, S. Vega, P. Ross, E. Freire. A design strategy that minimizes the susceptibility of HIV-1 protease inhibitors to mutations causing drug resistance. En: 16th Meeting of Groups Studying the Structures of AIDS-related Systems and their Application to Targeted Drug Design (NIH). Bethesda, 2002